2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
PMID:32644574
Treatment and prognosis of secondary glaucoma in Fuchs' heterochromic iridocyclitis.
La Hey E, de Vries J, Langerhorst CT, Baarsma GS, Kijlstra A.
Am J Ophthalmol. 1993 Sep 15;116(3):327-40. doi: 10.1016/s0002-9394(14)71350-9.
PMID:8357057
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C.
Esfandiari H, Loewen NA, Hassanpour K, Fatourechi A, Yazdani S, Wang C, Yaseri M, Pakravan M.
F1000Res. 2018 Jun 22;7:876. doi: 10.12688/f1000research.15244.2. eCollection 2018.
The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
Elgin U, Sen E, Ozdemir K, Ozdal P, Berker N.
Int Ophthalmol. 2020 Apr;40(4):795-802. doi: 10.1007/s10792-019-01240-3. Epub 2019 Dec 3.